To view the PDF file, sign up for a MySharenet subscription.

ANHEUSER-BUSCH INBEV SA/NV - Anheuser-Busch InBev reports Third Quarter and Nine Months 2017 Results

Release Date: 26/10/2017 07:06
Code(s): ANH     PDF:  
Wrap Text
Anheuser-Busch InBev reports Third Quarter and Nine Months 2017 Results

      Anheuser-Busch InBev SA/NV
      (Incorporated in the Kingdom of Belgium)
      Register of Companies Number: 0417.497.106
      Euronext Brussels Share Code: ABI
      Mexican Stock Exchange Share Code: ANB
      NYSE ADS Code: BUD
      JSE Share Code: ANH
      ISIN: BE0974293251
      (“AB InBev” or the “Company”)

      The enclosed information constitutes regulated information as defined in the Belgian Royal Decree of 14 November 2007 regarding the duties of
      issuers of financial instruments which have been admitted for trading on a regulated market.
      Except where otherwise stated, the comments below are based on organic figures and refer to 3Q17 and 9M17 versus the same period of last year.
      For a description of the reference base and important disclaimers please refer to pages 13 and 14.

                        Anheuser-Busch InBev reports Third Quarter and
                                  Nine Months 2017 Results
          HIGHLIGHTS
      -     Revenue: Revenue grew by 3.6% in 3Q17, with revenue per hl growth of 5.0%. On a constant
            geographic basis, revenue per hl grew by 5.4%, driven by revenue management initiatives and
            continued premiumization. In 9M17, revenue grew by 4.1% with revenue per hl growth of 4.5%. On a
            constant geographic basis, revenue per hl grew by 4.6%.
      -     Volume: Total volumes declined by 1.2% in 3Q17, with our own beer volumes down by 1.5%.
            Continued strong growth in Mexico, Argentina, and Africa was more than offset by soft shipment
            volumes in the US, primarily driven by the substantial weather impact in many parts of the country, and
            Brazil. In 9M17, total volumes declined by 0.3% with own beer volumes up 0.1%.
      -     Global Brands: Combined revenues of our three global brands, Budweiser, Stella Artois and Corona,
            grew by 1.6% in 3Q17 and by 7.3% in 9M17. Budweiser revenues declined by 2.2%, with 4.4% growth
            in revenues outside of the US led by Brazil, South Korea and Chile. Stella Artois revenues grew by
            0.9%, driven mainly by continued growth in Argentina and Brazil. Corona revenues grew by 9.6% with
            11.2% growth in revenues outside of Mexico, with strong growth in China, Colombia and Ecuador.
      -     Cost of Sales (CoS): CoS decreased by 1.9% in 3Q17 and by 0.5% on a per hl basis, driven by synergy
            capture as well as favorable emerging market exchange rates. On a constant geographic basis, CoS
            per hl was flat in 3Q17. In 9M17, CoS increased by 2.0%, by 2.5% on a per hl basis, and by 2.8% on a
            constant geographic basis.
      -     EBITDA increased by 13.8% in 3Q17, driven by revenue growth and continued synergy capture.
            EBITDA margin increased by 353 bps to 38.9% in 3Q17. In 9M17, EBITDA grew by 10.7% with EBITDA
            margin expanding by 230 bps to 38.0%.
      -     Net finance results: Net finance costs (excluding non-recurring net finance costs) decreased from
            1 226 million USD in 3Q16 to 1 135 million USD in 3Q17 predominantly due to a mark-to-market gain
            of 240 million USD in 3Q17, linked to the hedging of our share-based payment programs, compared to
            a loss of 57 million USD in 3Q16, resulting in a swing of 297 million USD. Net finance costs were
            4 255 million USD in 9M17 compared to 3 171 million USD in 9M16.
      -     Income taxes: Income tax in 3Q17 was 1 494 million USD compared to an income tax expense of 225
            million USD in 3Q16. The normalized effective tax rate (ETR) was 16.7% in 3Q17, compared to a
            normalized ETR of 11.7% in 3Q16. The normalized ETR was 19.1% in 9M17, up from 18.2% in 9M16.
      -     Profit: Normalized profit attributable to equity holders of AB InBev was 2 582 million USD in 3Q17
            compared to 1 363 million USD in 3Q16, driven by the organic increase in EBITDA and lower net


ab-inbev.com                                                                                                                                           1
           finance costs, partly offset by higher income tax expenses. Normalized profit attributable to equity
           holders of AB InBev was 5 913 million USD in 9M17, compared to 3 934 million USD in 9M16.
      -    Earnings per share (EPS): Normalized EPS increased to 1.31 USD in 3Q17 from 0.83 USD in 3Q16,
           primarily due to higher profits. Normalized EPS increased to 3.00 USD in 9M17 from 2.40 USD in 9M16.
      -    Interim Dividend: The AB InBev board has approved an interim dividend of 1.60 EUR per share for
           the fiscal year 2017. Details of ex-coupon, record and payment dates are shown on page 12.
      -    Combination with SAB: The business integration continues to progress well, with synergies and cost
           savings of 336 million USD captured during 3Q17. We are updating our 2.8 billion USD synergy and
           cost savings expectation to 3.2 billion USD on a constant currency basis as of August 2016.
      
      Figure 1. Consolidated performance (million USD)
                                                                                     3Q16               3Q16             3Q17         Organic
                                                                                 Reported     Reference Base                          growth
      Total Volumes (thousand hls)                                                121 027            162 944           161 045          -1.2%
                                                          AB InBev own beer       111 070            134 913           132 725          -1.5%
                                                           Non-beer volumes          9 158            27 241            27 085          -0.9%
                                                         Third party products          798                790            1 234         24.9%
      Revenue                                                                      11 109             14 210            14 740           3.6%
      Gross profit                                                                   6 716              8 511            9 194           7.1%
      Gross margin                                                                  60.5%              59.9%            62.4%         208 bps
      Normalized EBITDA                                                              4 032              5 039            5 733         13.8%
      Normalized EBITDA margin                                                      36.3%              35.5%            38.9%         353 bps
      Normalized EBIT                                                                3 214              3 995            4 681         17.6%
      Normalized EBIT margin                                                        28.9%              28.1%            31.8%         382 bps

      Profit attributable to equity holders of AB InBev                                557                               2 055
      Normalized profit attributable to equity holders of AB InBev                   1 363                               2 582

      Earnings per share (USD)                                                        0.34                                1.04
      Normalized earnings per share (USD)                                             0.83                                1.31
                                                                                     9M16               9M16             9M17         Organic
                                                                                 Reported     Reference Base                          growth
      Total Volumes (thousand hls)                                                340 803            456 441           466 595          -0.3%
                                                          AB InBev own beer       309 950            381 022           380 938           0.1%
                                                           Non-beer volumes        28 461             73 099            82 217          -2.9%
                                                         Third party products        2 392              2 319            3 440         17.7%
      Revenue                                                                      31 315             39 736            41 844           4.1%
      Gross profit                                                                 18 920             23 973            25 624           5.4%
      Gross margin                                                                  60.4%              60.3%            61.2%          77 bps
      Normalized EBITDA                                                            11 505             14 385            15 895         10.7%
      Normalized EBITDA margin                                                      36.7%              36.2%            38.0%         230 bps
      Normalized EBIT                                                                9 129            11 374            12 741         13.0%
      Normalized EBIT margin                                                        29.2%              28.6%            30.4%         245 bps

      Profit attributable to equity holders of AB InBev                                842                               4 963
      Normalized profit attributable to equity holders of AB InBev                   3 934                               5 913

      Earnings per share (USD)                                                         0.51                               2.52
      Normalized earnings per share (USD)                                              2.40                               3.00


      Figure 2. Volumes (thousand hls)
                                                                          3Q16   Scope        Organic           3Q17       Organic growth
                                                                     Reference                growth                        Total   Own beer
                                                                          Base                                            Volume      volume
      North America                                                     31 912      137         -1 939       30 109        -6.1%        -6.2%
      Latin America West                                                27 152      - 21           881       28 012         3.2%         3.4%
      Latin America North                                               28 947          6       -1 010       27 943        -3.5%        -4.1%
      Latin America South                                                7 478         -           333        7 811         4.5%         6.8%
      EMEA                                                              35 898      240          - 310       35 828        -0.9%        -0.5%
      Asia Pacific                                                      31 103       -91            24       31 037         0.1%        -0.5%
      Global Export and Holding Companies                                  455    - 172             21          304         7.4%         7.4%
      AB InBev Worldwide                                               162 944      100         -2 000      161 045        -1.2%        -1.5%




ab-inbev.com                                                                                                                               2
                                                         9M16     Scope       Organic      9M17      Organic growth
                                                    Reference                 growth                  Total   Own beer
                                                         Base                                       Volume      volume
      North America                                    90 351        348        -3 433    87 265     -3.8%        -3.9%
      Latin America West                               79 686        - 71        1 585    81 200      2.0%         2.0%
      Latin America North                              85 869           1       -1 377    84 493     -1.6%         0.0%
      Latin America South                              22 297           -        1 333    23 630      6.0%         9.1%
      EMEA                                             93 617     11 681           156   105 454      0.2%         1.5%
      Asia Pacific                                     83 265      - 111           450    83 605      0.5%         0.3%
      Global Export and Holding Companies               1 357      - 509           101       948     11.9%       11.9%
      AB InBev Worldwide                              456 441     11 339        -1 185   466 595     -0.3%         0.1%




       MANAGEMENT COMMENTS
      Our business continued to deliver solid results this quarter. Revenue grew by 3.6%, driven by revenue
      management and premiumization initiatives enhanced by our three global brands’ performances, especially
      outside of their home markets.

      Our EBITDA growth rate accelerated, up by 13.8% in 3Q17 and by 10.7% in 9M17, driven by solid top-line
      growth and disciplined cost management including synergy capture.

      We are also very proud of the 164 awards, of which 52 are gold medals, won at major beer competitions
      by AB InBev this year to date. Our most awarded brewery so far this year is 4 Pines from Australia, with an
      amazing 39 awards. We believe our impressive portfolio of high quality beers is key in enabling us to grow
      the global beer category.

      On 11 October 2017, we celebrated the first anniversary of our combination with SAB. We came together,
      learned from one another, and grew into a better, stronger company. Our integration continues to progress
      well, and as a result we have further increased our synergy guidance by 400 million USD to 3.2 billion USD,
      to be delivered within the same four year period following the close of the combination (by October 2020).
      These incremental synergies will be derived predominately from Best Practice Sharing and
      Procurement/Engineering Savings.

      As we enter the final months of the year, we will continue to push ourselves toward a strong finish. We have
      plenty of opportunities ahead of us, and look forward with excitement to further building on our dream of
      bringing people together for a better world.

      United States

      We estimate that industry STRs in the United States declined by 1.7% in 3Q17 and by 1.3% in 9M17. Our
      own STRs were down 3.4% in the quarter and down 3.1% in 9M17, while our STWs were down 6.4% in
      the quarter and down 4.0% in 9M17. The gap between STWs and STRs is attributable to disruptions from
      major hurricanes in Texas and Florida, but we expect this gap to be reduced in 4Q17 as STWs and STRs
      tend to converge on a full year basis. Our revenues, which are based on our STWs, decreased by 5.6% in
      3Q17 and by 2.8% in 9M17. Revenue per hl grew by 0.9% in 3Q17 and by 1.3% in 9M17.

      Our Above Premium brand portfolio accelerated this quarter, gaining approximately 50 bps of total market
      share (40 bps in 9M17). Michelob Ultra grew volumes by double-digits and was the top share gainer in the
      US for the tenth consecutive quarter, achieving the highest quarterly share gain in the past five years. Stella
      Artois had another strong quarter, as one of the top three fastest growing import brands on an STR basis,
      and our craft portfolio continues to gain share of segment.



ab-inbev.com                                                                                                         3
      The Premium and Premium Light segments continue to underperform the industry. Budweiser and Bud
      Light market share declined by 45 and 95 bps this quarter, respectively.

      Budweiser’s “American Summer” campaign and the return of the “America” packaging contributed to
      upward trends in brand health and led to Budweiser becoming the leading brand in the industry in ad
      awareness and consideration growth in 3Q17. We plan to leverage this momentum into the fourth quarter,
      when we will bring a seasonal Budweiser variant that celebrates the repeal of Prohibition with one of our
      heritage recipes.

      In 3Q17, we launched Bud Light’s new Quality campaign and an array of new content tied to the Friendship
      platform, which was well-received by consumers and positively impacted brand equity. We have been
      customizing content to identify with consumers at a more local level, and as we see improvement in
      activated markets, we will continue to expand the program.

      Our Value brand portfolio, led by the Busch brand family, also performed well this quarter.

      We are driving the momentum behind our SpikedSeltzer and Teavana brands, as we expand our portfolio
      beyond traditional beer. Teavana is now the number one super premium ready-to-drink tea in the markets
      where we launched earlier this year, and SpikedSeltzer continues to grow share and volume.

      Overall, we estimate a decline in total market share of approximately 80 bps in 3Q17, representing a
      sequential improvement on 2Q17 and in line with 9M17. Our market share remains under pressure while
      we continue to balance the share and profitability equation. However, we are encouraged by the share
      growth of our Above Premium brands, as well as the improved responses to the new content in our
      marketing campaigns. Our premiumization strategy and tight cost management enabled the continued
      expansion of our gross profit margin, which grew by 94 bps to 62.0%, as well as the delivery of EBITDA
      margin expansion of 211 bps to 42.2% in the quarter, the highest level in thirteen quarters. However, the
      hurricanes accounted for an estimated 2 pp reduction to EBITDA growth in the quarter, resulting in an
      EBITDA decline of 0.7% versus 3Q16. In 9M17, EBITDA grew by 0.7% with EBITDA margin expansion of
      145 bps to 41.6%.

      Mexico

      Our business in Mexico continued to perform well in the quarter, with double-digit revenue growth driven
      by mid-single digit volume and revenue per hl growth, in line with the year to date performance, despite the
      negative impact of the earthquakes that hit Mexico during the month of September.

      Victoria and Corona Extra each secured growth in the core segment, while Bud Light and the Modelo Family
      converted high consumer engagement on special occasions into volume growth in the core plus segment.
      With respect to our global brand portfolio, we continue to sharpen the premium positioning of Budweiser,
      while Stella Artois benefitted from continued communication surrounding food pairing.

      EBITDA grew by 8.3% in Mexico in 3Q17, with margin compression of 110 bps to 42.7%. As in previous
      quarters, operating leverage was constrained by the impact of currency devaluation on our CoS as well as
      elevated distribution costs caused by the combined effect of a 30% increase in fuel costs at the beginning
      of the year and pressure on the production grid to meet regional and global demand. In 9M17, EBITDA
      grew by 9.3% with margin contraction of 18 bps to 42.7%.

      Colombia

      In Colombia, our revenue grew by 6.7% in 3Q17, driven by revenue per hl growth of 6.6%. Our non-beer
      volumes performed very well, growing by 10.3%, due to a favorable comparable and enhanced by a
      successful national promotion of Pony Malta. Our beer volumes declined by 1.4%, as the macroeconomic

ab-inbev.com                                                                                                    4
      environment remains challenging with consumer confidence and real disposable income under continued
      pressure.

      The Aguila brand performed well this quarter, with a new “Days of Soccer” campaign focused on driving
      consumption on weekday occasions as well as the launch of a new equity campaign. Our local premium
      brand, Club Colombia, also had a strong quarter as a result of successful brand variants such as Trigo and
      Oktoberfest. Our global brands continued their rapid growth, with Corona leading the way and becoming
      the country’s biggest international premium brand by volume.

      Our EBITDA in Colombia grew by 4.7% in 3Q17, with margin contraction of 95 bps. This result was driven
      by top-line growth and synergy capture, partially offset by the phasing of sales and marketing investments
      as well as the release of certain provisions in the prior year. In 9M17, EBITDA grew by 4.6% with margin
      expansion of 132 bps.
      Brazil

      In Brazil, our revenue grew by 8.6% in 3Q17 with net revenue per hl growth of 13.1% and a volume decline
      of 4.0%. Beer volumes were down by 5.4% in the quarter, impacted by an industry that is still in recovery
      and by the fact that in the prior year, price increases were delayed until the fourth quarter, creating a difficult
      comparable.

      In 9M17, revenue increased by 2.0% with net revenue per hl growth of 4.0% and a volume decline of 1.9%.
      Beer volumes were down by 1.1%, outperforming the industry thus far this year.

      Revenue per hl growth was aided by double-digit growth in our high end portfolio with continued strong
      growth in all three global brands, especially Budweiser. With respect to our local brands, the core plus
      portfolio also grew by double-digits, led by Brahma Extra and Bohemia. Our Brazilian portfolio received the
      most awards of any of our markets at the World Beer Awards in the UK during the quarter, reinforcing the
      quality credentials of our national beers.

      Our revenue management initiatives implemented during 3Q17 contributed to the increase in net revenue
      per hl that, along with an improved cost performance, translated into EBITDA growth of 14.5%. Strong
      EBITDA growth in our beer business partly offset by an EBITDA decline in our non-beer business, which
      was heavily impacted by commodity price escalation in the quarter. We retain our previous guidance for a
      flattish to low single digit increase in CoS per hl in the second half of 2017. Our EBITDA margin expanded
      by 201 bps to 39.0% in 3Q17. In 9M17, our EBITDA declined by 9.5%, with margin contraction of 496 bps
      to 39.0%.

      We believe that the revenue growth achieved this quarter signals a return to sustainable growth from a
      strengthened market position in our beer business. We remain cautiously optimistic about the Brazilian
      economy, and are confident in our commercial plans and our ability to accelerate EBITDA growth and
      margin recovery for the balance of the year.

      South Africa

      Our beer revenues in South Africa grew by 3.9% in 3Q17, with revenue per hl growth of 6.6% partially offset
      by beer volume declines of 2.5%. This decline primarily resulted from the phasing of inventory levels
      between 2Q17 and 3Q17 due to the timing of our price increases. In 9M17, revenue grew by 7.5% with
      revenue per hl growth of 5.3% and beer volume growth of 2.1%.

      Our high end portfolio continued to deliver strong growth in Stella Artois and Corona, and we recently began
      seeding Budweiser into the market to complete our global brand portfolio in South Africa. Castle Lite
      performed well this quarter with volumes growing by double-digits, as the brand focuses on growing the in-
      home consumption occasion heading into the summer season. Flying Fish also continues to perform

ab-inbev.com                                                                                                           5
      extremely well, targeting mixed gender occasions and launching “Flying Fish Chill” in September, the first
      light flavored beer in South Africa.

      Strong top-line growth, combined with synergy capture, resulted in EBITDA growth of 30.7% with margin
      expansion of 645 bps in 3Q17. In 9M17, our EBITDA grew by 23.6% with margin expansion of 502 bps.

      China

      Revenue in China grew by 4.6% in the quarter with continued premiumization driving revenue per hl growth
      of 4.8%, despite slightly lower volumes of 0.2%, which was driven by industry headwinds concentrated in
      the Northeastern and Southern provinces. Revenue for 9M17 grew by 7.4% with revenue per hl up 5.7%
      and volume growth of 1.6%.

      Budweiser continued to excel in all brand health metrics, growing preference and penetration supported by
      occasion-focused pack innovation. Harbin Ice enjoyed high single digit volume growth, building on strong
      momentum in the first half, aided by the wheat-based Harbin Baipi innovation.

      Our super premium portfolio, led by Corona, Hoegaarden, and Franziskaner, grew by high double-digits.
      These brands, with their unique brand characteristics and positioning, continue to exhibit strong growth
      among LDA mixed gender consumers in high end outlets and premium occasions. They are also driving
      further margin expansion, with gross margins of approximately 10 times those of core brands in China.

      EBITDA grew by 12.0% in 3Q17, with margin expansion of 193 bps to 29.0%. This is a result of strong
      top-line growth combined with effective cost management. In 9M17, EBITDA was up 22.8% with margin
      expansion of over 400 bps to 32.6%.

      Highlights from our other markets

      Canada experienced a challenging third quarter due to a softer beer industry leading to a low single digit
      volume decline. Market share performance continues to be solid, with Bud Light accelerating momentum
      and continued growth in the high end segment, with both our craft portfolio and Stella Artois gaining share.
      We have also achieved the leadership position in the cider market, which continues to grow by double-
      digits, and are seeing strong performance in our ready-to-drink innovations.

      Peru delivered revenue growth of 5.4% with volumes up 1.0%, driven by commercial initiatives and growth
      within both the beer and non-beer categories. Ecuador also recorded revenue growth of 11.9% and volume
      growth of 6.5% in the quarter as a result of top-line initiatives including the launch of global brands, as well
      as cycling a favorable comparable after the earthquake in April 2016.

      Argentina delivered double-digit beer volume growth, with enhanced commercial initiatives continuing to
      drive good results for both our core and premium portfolio. We also gained share of total alcohol this quarter
      through successful targeting of the in-home consumption occasion.

      Within EMEA, we had another solid quarter in Western Europe, achieving market share gains in most of
      our markets. The UK continued to deliver double-digit top-line growth, resulting from a strong commercial
      performance. In Eastern Europe, revenues declined by low single digits driven by the ongoing headwind
      of the large PET ban in Russia. However, our global and premium brands continue their strong growth. In
      Africa excluding South Africa, own beer volumes grew in the mid-teens, fueled by good growth in Nigeria,
      Tanzania, Uganda, Mozambique and Zambia.

      Australia continues to see a strong performance, led by the Great Northern franchise, our number one
      brand in Australia in 3Q17. We also became the number one cider player in Australia for the past twelve
      months, driven by the growth of Pure Blonde Cider and Mercury Hard Cider. We continue to grow our Craft

ab-inbev.com                                                                                                        6
      portfolio, including the newly acquired 4 Pines based in New South Wales. Our global brands continue to
      perform well, with increased penetration and distribution across the country. However, revenues declined
      by mid-single digits this quarter, with volumes down by high single digits, due to the change of control
      impact of the legacy AB InBev portfolio, which led to a difficult comparable in 3Q16. We expect this impact
      to normalize in 4Q17. Revenue per hl increased by mid-single digits in the quarter.


      2017 OUTLOOK

      (i)     Top-line: While recognizing the increased volatility in some of our key markets, we expect to
              accelerate total revenue growth in FY17, driven by the solid growth of our global brands and strong
              commercial plans, including revenue management initiatives.
      (ii)    Cost of Sales: We expect CoS per hl to increase by low single digits on a constant geographic basis,
              despite unfavorable foreign exchange transactional impacts, and growth in our premium brands.
      (iii)   Selling, General and Administrative Expenses: We expect SG&A to remain broadly flat, as we will
              continue to find savings in overhead to invest behind our brands.
      (iv)    Synergies: We are updating our 2.8 billion USD synergy and cost savings expectation to 3.2 billion
              USD on a constant currency basis as of August 2016. From this total, 547 million USD was reported
              by SAB as of 31 March 2016, and 1 205 million USD was captured between 1 April 2016 and
              30 September 2017. The balance of approximately 1.45 billion USD is expected to be captured in the
              next three years.

              The breakdown of our revised synergy guidance is as follows:

                  -   Procurement & Engineering Savings – 29% (previously 25%)
                  -   Brewery & Distribution Efficiencies – 19% (previously 25%)
                  -   Corporate Headquarter/Overlapping Regional Headquarters – 18% (previously 20%)
                  -   Best Practice Sharing – 34% (previously 30%)
              We are also updating the estimated one-off cash costs required to deliver the synergies to 1.0 billion
              USD, an increase of 100 million USD, to be incurred in the first three years of integration.

      (v)     Net Finance Costs: We expect the average rate of interest on net debt in FY17 to be in the range of
              3.5% to 4.0%. Net pension interest expenses and accretion expenses are expected to be
              approximately 30 and 150 million USD per quarter, respectively. Other financial results will continue
              to be impacted by any gains and losses related to the hedging of our share-based payment programs.
      (vi)    Effective Tax Rate (ETR): We expect the normalized ETR in FY17 to be in the range of 22% to 24%,
              excluding any future gains and losses relating to the hedging of our share based programs. This
              guidance continues to include the impact of the change in country mix following the combination with
              SAB and the expected tax consequences of the funding of the combination. At this point, we expect
              to be at the lower end of this range.
      (vii)   Net Capital Expenditure: We expect net capital expenditure of approximately 3.7 billion USD in
              FY17.
      (viii) Debt: Approximately one third of our gross debt is denominated in currencies other than the USD,
             principally the Euro. Our optimal capital structure remains a net debt to EBITDA ratio of around 2x.
      (ix)    Dividends: We continue to expect dividends to be a growing flow over time, although growth in the
              short term is expected to be modest given the importance of deleveraging.


ab-inbev.com                                                                                                      7
       CONSOLIDATED INCOME STATEMENT

      Figure 3. Consolidated income statement (million USD)
                                                                 3Q16                3Q16     3Q17      Organic
                                                              Reported     Reference Base               growth
      Revenue                                                   11 109             14 210   14 740         3.6%
      Cost of sales                                             -4 393             -5 698   -5 546         1.9%
      Gross profit                                               6 716              8 511    9 194         7.1%
      SG&A                                                      -3 649             -4 716   -4 652         3.4%
      Other operating income/(expenses)                            147                200      139       -34.4%
      Normalized profit from operations (normalized EBIT)        3 214              3 995    4 681        17.6%
      Non-recurring items above EBIT                              -138                        -173
      Net finance income/(cost)                                 -1 226                      -1 135
      Non-recurring net finance income/(cost)                    - 678                         177
      Share of results of associates                                 3                          88
      Income tax expense                                         - 225                      -1 494
      Profit from continuing operations                            950                       2 144
      Discontinued operations results                                -                           -
      Profit                                                       950                       2 144
      Profit attributable to non-controlling interest              394                          89
      Profit attributable to equity holders of AB InBev            557                       2 055

      Normalized EBITDA                                           4 032             5 039     5 733      13.8%
      Normalized profit attributable to equity
      holders of AB InBev                                         1 363                       2 582

                                                                 9M16                9M16     9M17      Organic
                                                              Reported     Reference Base               growth
      Revenue                                                    31 315            39 736    41 844        4.1%
      Cost of sales                                             -12 395           -15 764   -16 220       -2.0%
      Gross profit                                               18 920            23 973    25 624        5.4%
      SG&A                                                      -10 360           -13 291   -13 431        2.0%
      Other operating income/(expenses)                             569               692       547      -16.2%
      Normalized profit from operations (normalized EBIT)         9 129            11 374    12 741       13.0%
      Non-recurring items above EBIT                              - 276                       - 460
      Net finance income/(cost)                                  -3 171                      -4 255
      Non-recurring net finance income/(cost)                    -2 846                         - 34
      Share of results of associates                                   5                        213
      Income tax expense                                         -1 059                      -2 487
      Profit from continuing operations                           1 780                       5 716
      Discontinued operations results                                 -                           28
      Profit                                                      1 780                       5 745
      Profit attributable to non-controlling interest               938                         782
      Profit attributable to equity holders of AB InBev             842                       4 963

      Normalized EBITDA                                         11 505             14 385   15 895       10.7%
      Normalized profit attributable to equity
      holders of AB InBev                                         3 934                       5 913


      Revenue

      Consolidated revenue grew by 3.6% in 3Q17, with revenue per hl growth of 5.0%, driven by our revenue
      management and premiumization initiatives. On a constant geographic basis, revenue per hl grew by 5.4%.
      In 9M17, revenue grew by 4.1%, with revenue per hl growth of 4.5% on an organic basis and 4.6% on a
      constant geographic basis.

      Cost of Sales (CoS)

      Total CoS decreased by 1.9%, and by 0.5% on a per hl basis in 3Q17. This decrease was driven by synergy
      capture as well as favorable transactional foreign exchange impacts. On a constant geographic basis, CoS
      per hl was flat. In 9M17, total CoS increased by 2.0%, by 2.5% on a per hl basis and by 2.8% per hl on a
      constant geographic basis.


ab-inbev.com                                                                                                 8
      Selling, General and Administrative Costs (SG&A)

      SG&A declined by 3.4%, reflecting strong cost discipline combined with good synergy capture. In 9M17,
      SG&A declined by 2.0%.

      Other operating income/(expenses)

      Other operating income decreased organically by 34.4% to 139 million USD in 3Q17 as government grants
      received in the previous year in Brazil were not repeated. Other operating income decreased by 16.2% to
      547 million USD in 9M17.

      Non-recurring items above EBIT

      Figure 4. Non-recurring items above EBIT (million USD)
                                                                                     3Q16      3Q17      9M16      9M17
      Restructuring                                                                    - 29    - 119       - 92    - 407
      Acquisition costs / Business combinations                                      - 105       - 18    - 183       - 43
      Business and asset disposal (including impairment losses)                          -4      - 36        -2      - 10
      Impact on profit from operations                                               - 138     - 173     - 276     - 460


      Normalized profit from operations excludes negative non-recurring items of 173 million USD in 3Q17,
      primarily related to the one-off restructuring costs related to the SAB integration.

      Figure 5. Net finance income/(cost) (million USD)
                                                                                     3Q16      3Q17      9M16      9M17
      Net interest expense                                                           - 881     - 999    -2 428    -3 056
      Net interest on net defined benefit liabilities                                  - 24      - 27      - 83      - 82
      Accretion expense                                                              - 143     - 149     - 406     - 452
      Other financial results                                                        - 178         40    - 254     - 665
      Net finance income/(cost)                                                     -1 226    -1 135    -3 171    -4 255


      Net finance costs (excluding non-recurring net finance costs) were 1 135 million USD in 3Q17 compared
      to 1 226 million USD in 3Q16. Net interest expense increased from 881 million USD to 999 million USD.
      Other financial results are negatively impacted by foreign exchange losses offset by a mark-to-market gain
      of 240 million USD in 3Q17, linked to the hedging of our share-based payment programs, compared to a
      loss of 57 million USD in 3Q16.

      Net finance costs in 9M17 were 4 255 million USD compared to 3 171 million USD in 9M16. This increase
      in net finance costs was driven primarily by additional debt related to the SAB combination and interest
      expenses on the legacy SAB debt. Other finance results in 9M17 were negatively impacted by foreign
      exchange losses partially offset by a positive mark-to-market adjustment of 105 million USD, linked to the
      hedging of our share-based payment programs, compared to a gain of 249 million USD in 9M16.

      The number of shares covered by the hedging of our share-based payment programs, and the opening and
      closing share prices, are shown in figure 6 below.

      Figure 6. Share-based payment hedge
                                                                                     3Q16      3Q17      9M16      9M17
      Share price at the start of the period (Euro)                                 117.60     96.71    114.40    100.55
      Share price at the end of the period (Euro)                                   116.60    101.30    116.60    101.30
      Number of equity derivative instruments at the end of the period (millions)     44.2      46.9      44.2      46.9




ab-inbev.com                                                                                                           9
      Non-recurring net finance income/(cost)

      Figure 7. Non-recurring net finance income/(cost) (million USD)
                                                                                                      3Q16      3Q17     9M16     9M17
      Mark-to-market (Grupo Modelo deferred share instrument)                                          - 22      113      124       42
      Mark-to-market (Portion of the FX hedging of the purchase price of the combination with
                                                                                                      - 594         -   -2 959        -
      SABMiller that did not qualify for hedge accounting)
      Other mark-to-market                                                                              - 17     109       276        40
      Other                                                                                             - 45     - 45    - 287    - 116
      Non-recurring net finance income/(cost)                                                         - 678      177    -2 846      - 34


      Non-recurring net finance income was 177 million USD in 3Q17 compared to a cost of 678 million USD
      in 3Q16. Non-recurring net finance costs in 3Q16 included a negative mark-to-market adjustment of 594
      million USD, related to the portion of the FX hedging of the purchase price of the combination with SAB that
      did not qualify for hedge accounting under IFRS rules.

      The 3Q17 result includes a positive mark-to-market adjustment on our non-recurring equity derivatives
      related to the hedging of the deferred share instrument in connection with the Grupo Modelo combination
      and the restricted share instrument in connection with the SAB combination. The number of shares covered
      by the respective hedgings are shown in figure 8, together with the opening and closing share prices.

      Figure 8. Non-recurring equity derivative instruments
                                                                                                      3Q16      3Q17     9M16     9M17
      Share price at the start of the period (Euro)                                                  117.60     96.71   114.40   100.55
      Share price at the end of the period (Euro)                                                    116.60    101.30   116.60   101.30
      Number of equity derivative instruments at the end of the period (millions)                      38.1      45.5     38.1     45.5


      Figure 9. Income tax expense (million USD)
                                                                                                      3Q16      3Q17     9M16     9M17
      Income tax expense                                                                               225      1 494    1 059    2 487
      Effective tax rate                                                                             19.2%     42.1%    37.4%    31.1%
      Normalized effective tax rate                                                                  11.7%     16.7%    18.2%    19.1%


      The normalized effective tax rate reached 16.7% in 3Q17 compared to 11.7% in 3Q16.

      The effective tax rate was 42.1% in 3Q17 compared to 19.2% in 3Q16. The increase results from Ambev
      and certain of its subsidiaries joining the Brazilian Tax Regularization Program in September 2017 whereby
      Ambev committed to pay some tax contingencies that were under dispute, totaling 3.5 billion BRL (1.1
      billion USD), with 1.0 billion BRL (0.3 billion USD) to be paid this year. The remaining amount is payable in
      145 monthly installments beginning in January 2018, plus interest. Within these contingencies, a dispute
      related to presumed taxation at Ambev’s subsidiary CRBs was not provided for until 3Q17 as the loss was
      previously assessed as possible. The total amount recognized as non-recurring is 3.1 billion BRL (1.0 billion
      USD) of which 3.0 billion BRL (0.9 billion USD) is reported as income tax and 141 million BRL (44 million
      USD) is reported as net finance cost.

      Figure 10. Normalized Profit attribution to equity holders of AB InBev (million USD)
                                                                                                      3Q16      3Q17     9M16     9M17
      Profit attributable to equity holders of AB InBev                                                 557     2 055      842    4 963
      Non-recurring items, after taxes, attributable to equity holders of AB InBev                      128       704      246      944
      Non-recurring finance (income)/cost, after taxes, attributable to equity holders of AB InBev      678     - 177    2 846        34
      Discontinued operations results                                                                     -         -        -      - 28
      Normalized profit attributable to equity holders of AB InBev                                    1 363     2 582    3 934    5 913




ab-inbev.com                                                                                                                       10
      Normalized and Basic EPS

      Figure 11. Earnings per share (USD)
                                                                                                                         3Q16            3Q17        9M16       9M17
      Basic earnings per share                                                                                            0.34            1.04        0.51       2.52
      Non-recurring items, after taxes, attributable to equity holder of AB InBev, per share                              0.08            0.36        0.15       0.48
      Non-recurring finance (income)/cost, after taxes, attributable to equity holders of AB InBev, per
      share                                                                                                               0.41           -0.09        1.73        0.02
      Discontinued operations results, per share                                                                             -               -           -       -0.01
      Normalized earnings per share                                                                                       0.83            1.31        2.40        3.00


      Normalized earnings per share (EPS) increased from 0.83 USD in 3Q16 to 1.31 USD in 3Q17, primarily
      driven by the increase in profit and partially offset by a higher number of shares.

      Basic earnings per share increased from 0.34 USD in 3Q16 to 1.04 USD in 3Q17. The 3Q17 basic earnings
      per share is negatively impacted by the non-recurring taxes accrued by Ambev when it joined the Brazilian
      Tax Regularization Program. The 3Q16 basic earnings per share were negatively impacted by losses on
      hedges related to the SAB combination that did not qualify for hedge accounting.

      Figure 12. Key components - Normalized Earnings per share in USD
                                                                                                                                 3Q16       3Q17      9M16      9M17
      Normalized EBIT                                                                                                             1.96       2.85      5.56      7.76
      Mark-to-market (Hedging of our share-based payment programs)                                                               -0.04       0.14      0.15      0.06
      Pre-funding of SAB transaction                                                                                             -0.28          -     -0.74         -
      Net finance cost                                                                                                           -0.42      -0.83     -1.34     -2.65
      Income tax expense                                                                                                         -0.14      -0.36     -0.66     -0.99
      Associates & non-controlling interest                                                                                      -0.25      -0.23     -0.57     -0.58
      Share dilution                                                                                                                 -      -0.26         -     -0.60
      Normalized EPS                                                                                                              0.83       1.31      2.40      3.00

      Note: 9M16 and 9M17 before dilution calculated based upon weighted average number of shares per 9M16 of 1 641 million shares.
      EPS after dilution based upon weighted average number of shares per 9M17 of 1 970 million shares.



      Reconciliation between profit attributable to equity holders and normalized EBITDA

      Figure 13. Reconciliation of normalized EBITDA to profit attributable to equity holders of AB InBev (million USD)
                                                                                                       3Q16           3Q17                             9M16     9M17
                                                                                                   Reported                                         Reported
      Profit attributable to equity holders of AB InBev                                                  557          2 055                              842    4 963
      Non-controlling interests                                                                          394              89                             938      782
      Profit                                                                                             950          2 144                            1 780    5 745
      Discontinued operations results                                                                      -               -                               -      - 28
      Profit from continuing operations                                                                  950          2 144                            1 780    5 716
      Income tax expense                                                                                 225          1 494                            1 059    2 487
      Share of result of associates                                                                       -3            - 88                              -5    - 213
      Net finance (income)/cost                                                                        1 226          1 135                            3 171    4 255
      Non-recurring net finance (income)/cost                                                            678          - 177                            2 846        34
      Non-recurring items above EBIT (incl. non-recurring impairment)                                    138            173                              276      460
      Normalized EBIT                                                                                  3 214          4 681                            9 129   12 741
      Depreciation, amortization and impairment                                                          818          1 052                            2 377    3 154
      Normalized EBITDA                                                                                4 032          5 733                           11 505   15 895


      Normalized EBITDA and normalized EBIT are measures utilized by AB InBev to demonstrate the
      company’s underlying performance.

      Normalized EBITDA is calculated excluding the following effects from profit attributable to equity holders of
      AB InBev: (i) non-controlling interest; (ii) discontinued operations results; (iii) income tax expense; (iv) share
      of results of associates; (v) net finance cost; (vi) non-recurring net finance cost; (vii) non-recurring items
      above EBIT (including non-recurring impairment); and (viii) depreciation, amortization and impairment.

      Normalized EBITDA and normalized EBIT are not accounting measures under IFRS accounting and should
      not be considered as an alternative to profit attributable to equity holders as a measure of operational


ab-inbev.com                                                                                                                                                      11
      performance, or an alternative to cash flow as a measure of liquidity. Normalized EBITDA and normalized
      EBIT do not have a standard calculation method and AB InBev’s definition of normalized EBITDA and
      normalized EBIT may not be comparable to that of other companies.




       INTERIM DIVIDEND

      The AB InBev board has approved an interim dividend of 1.60 EUR per share for the fiscal year 2017.

                                           Ex-coupon date           Record Date             Payment Date
      Euronext: ABI                       14 November 2017        15 November 2017        16 November 2017
      MEXBOL: ANB                         14 November 2017        15 November 2017        16 November 2017
      JSE: ANH                            15 November 2017        17 November 2017        20 November 2017
      NYSE: BUD (ADR Program)             14 November 2017        15 November 2017        07 December 2017
      Restricted Shares                   14 November 2017        15 November 2017        16 November 2017




       RECENT EVENTS

      1. Extension of 9.0 billion USD revolving credit facility

      We extended our 9.0 billion USD revolving credit facility by two years, effective on 3 October 2017. The
      new maturity date of the facility is 30 August 2022.

      2. Completion of Coca-Cola Beverages Africa disposal

      On 4 October 2017, we announced that the transition of our 54.5% equity stake in Coca-Cola Beverages
      Africa (Pty) Ltd (“CCBA”) for 3.15 billion USD, after customary adjustments, as announced on 21 December
      2016, has now been completed.
      CCBA, the largest Coca-Cola bottler in Africa, was formed in 2016 through the combination of the African
      non-alcohol ready-to-drink bottling interests of former SABMiller plc, The Coca-Cola Company and Gutsche
      Family Investments. It includes the countries of South Africa, Namibia, Kenya, Uganda, Tanzania, Ethiopia,
      Mozambique, Ghana, Mayotte, and Comoros.
      Following completion, CCBA will remain subject to the agreement reached with the South African
      Government and the South African Competition Authorities on several conditions, all of which were
      previously announced.
      In addition, the companies continue to work towards finalizing the terms and conditions of the agreement
      for The Coca-Cola Company to acquire our interest in, or the bottling operations of, our businesses in
      Zambia, Zimbabwe, Botswana, Swaziland, Lesotho, El Salvador, and Honduras. These transactions are
      subject to the relevant regulatory and shareholder approvals in the different jurisdictions.




ab-inbev.com                                                                                                 12
      3. Early redemption of notes

      On 11 October 2017, we announced that we are exercising our respective options to redeem in full the
      entire outstanding principal amount of the following series of notes on 10 November 2017:
                                                                                                     Aggregate principal amount
                     Issuer                                   Title of series of notes                     (Million USD)
          Anheuser-Busch InBev Finance                        1.25% Notes due 2018                             1 000
         Anheuser-Busch InBev Worldwide                       6.50% Notes due 2018                              627
           Anheuser-Busch Companies                           4.50% Notes due 2018                              200
           Anheuser-Busch Companies                           5.50% Notes due 2018                              500
          ABI SAB Group Holding Limited                       6.50% Notes due 2018                               73

      The total principal amount of the notes that will be retired is approximately 2.4 billion USD and the
      redemption of the notes will be financed with cash.


       NOTES
      To facilitate the understanding of AB InBev’s underlying performance, the analyses of growth, including all comments in this press
      release, unless otherwise indicated, are based on organic growth and normalized numbers. In other words, financials are analyzed
      eliminating the impact of changes in currencies on translation of foreign operations, and scope changes. Scope changes represent
      the impact of acquisitions and divestitures, the start or termination of activities or the transfer of activities between segments,
      curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not
      consider as part of the underlying performance of the business.

      All references per hectoliter (per hl) exclude US non-beer activities. To eliminate the effect of geography mix, i.e. the impact of stronger
      volume growth coming from countries with lower revenue per hl, and lower Cost of Sales per hl, we are also presenting, where
      specified, organic growth per hectoliter figures on a constant geographic basis. When we make estimations on a constant geographic
      basis, we assume each country in which we operate accounts for the same percentage of our global volume as in the same period of
      the previous year.

      Whenever presented in this document, all performance measures (EBITDA, EBIT, profit, tax rate, EPS) are presented on a
      “normalized” basis, which means they are presented before non-recurring items and discontinued operations. Non-recurring items are
      either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately
      because they are important for the understanding of the underlying sustainable performance of the Company due to their size or
      nature. Normalized measures are additional measures used by management, and should not replace the measures determined in
      accordance with IFRS as an indicator of the Company’s performance. The results of the CEE business are presented as “discontinued
      operations result” until their disposal on 31 March 2017. Values in the figures and annexes may not add up, due to rounding.

      Given the transformational nature of the transaction with SAB that closed on 10 October 2016, and to facilitate the understanding of
      AB InBev’s underlying performance, AB InBev has updated its 3Q16 and 9M16 segment reporting for purposes of this results
      announcement and internal review by senior management. This presentation (referred to as the “Reference Base”) includes, for
      comparative purposes, the results of the SAB business as if the combination had taken place at the beginning of 4Q15, but excluding
      the results of (i) those business sold since the combination was completed, including the joint venture stakes in MillerCoors and CR
      Snow, and the sale of the Peroni, Grolsch and Meantime brands and associated businesses in Italy, the Netherlands, the UK and
      internationally and (ii) the Central and Eastern Europe business and the stake in Distell. The changes, effective 1 October 2016,
      include the former SAB geographies. Colombia, Peru, Ecuador, Honduras and El Salvador are reported together with Mexico as Latin
      America West, Panama is reported within Latin America North, Africa is reported together with Europe as EMEA, and Australia, India
      and Vietnam are reported within APAC.

      3Q17 and 9M17 EPS is based upon a weighted average of 1 970 million shares compared to a weighted average of 1 641 million
      shares for 3Q16 and 9M16.




ab-inbev.com                                                                                                                                  13
      Legal Disclaimer
      This release contains “forward-looking statements”. These statements are based on the current expectations and views of future
      events and developments of the management of AB InBev and are naturally subject to uncertainty and changes in circumstances.
      The forward-looking statements contained in this release include, among other things, statements relating to AB InBev’s business
      combination with SAB and other statements other than historical facts. Forward-looking statements include statements typically
      containing words such as “will”, “may”, “should”, “believe”, “intends”, “expects”, “anticipates”, “targets”, “estimates”, “likely”, “foresees”
      and words of similar import. All statements other than statements of historical facts are forward-looking statements. You should not
      place undue reliance on these forward-looking statements, which reflect the current views of the management of AB InBev, are subject
      to numerous risks and uncertainties about AB InBev and are dependent on many factors, some of which are outside of AB InBev’s
      control. There are important factors, risks and uncertainties that could cause actual outcomes and results to be materially different,
      including the ability to realize synergies from the business combination with SAB, the risks and uncertainties relating to AB InBev
      described under Item 3.D of AB InBev’s Annual Report on Form 20-F (“Form 20-F”) filed with the US Securities and Exchange
      Commission (“SEC”) on 22 March 2017. Other unknown or unpredictable factors could cause actual results to differ materially from
      those in the forward-looking statements.

      The forward-looking statements should be read in conjunction with the other cautionary statements that are included elsewhere,
      including AB InBev’s most recent Form 20-F and other reports furnished on Form 6-K, and any other documents that AB InBev or
      SAB have made public. Any forward-looking statements made in this communication are qualified in their entirety by these cautionary
      statements and there can be no assurance that the actual results or developments anticipated by AB InBev will be realized or, even
      if substantially realized, that they will have the expected consequences to, or effects on, AB InBev or its business or operations. Except
      as required by law, AB InBev undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result
      of new information, future events or otherwise.

      The 2016 Reference Base information is based in part on certain assumptions that AB InBev believes are reasonable under the
      circumstances. The 2016 Reference Base information is presented for illustrative purposes only and does not necessarily reflect the
      results of operations or the financial position of the combined former AB InBev and SAB groups that would have resulted had the
      combination occurred on 8 October 2015, or project the results of operations or financial position of the combined group for any future
      date or period. The 2016 Reference Base information is not pro forma financial information, and has not been prepared in accordance
      with Article 11 of Regulation S-X promulgated by the U.S. Securities and Exchange Commission. It is therefore not consistent in terms
      of content and presentation with pro forma financial information that has been or will be included in reports filed under Sections 13(a)
      or 15(d) of the U.S. Securities Exchange Act of 1934, as amended.


      The third quarter 2017 (3Q17) and nine months (9M17) financial data set out in Figure 1 (except for the volume information), Figures
      3 to 5, 7, 9 to 11 and 13 of this press release have been extracted from the group’s unaudited condensed consolidated interim financial
      statements as of and for the nine months ended 30 September 2017, which have been reviewed by our statutory auditors Deloitte
      Bedrijfsrevisoren BCVBA in accordance with the standards of the Public Company Accounting Oversight Board (United States). The
      auditors concluded that, based on their review, nothing had come to their attention that caused them to believe that those interim
      financial statements were not prepared fairly, in all material respects, in accordance with IAS 34 “Interim Financial Reporting”, as
      issued by the IASB and as adopted by the European Union. Financial data included in Figures 6, 8 and 12 have been extracted from
      the underlying accounting records as of and for the nine months ended 30 September 2017 (except for the volume information).



       CONFERENCE CALL AND WEBCAST

      Investor Conference call and Webcast on Thursday, 26 October 2017:

      3.00pm Brussels / 2.00pm London / 9.00am New York

      Registration details

      Webcast (listen-only mode)
      http://bit.ly/2gkWe2P
      Conference call (with interactive Q&A)
      http://bit.ly/2uGfb9e




ab-inbev.com                                                                                                                                    14
       ANHEUSER-BUSCH INBEV CONTACTS

      Media                                                                  Investors
      Marianne Amssoms                                                       Henry Rudd
      Tel: +1-212-573-9281                                                   Tel: +1-212-503-2890
      E-mail: marianne.amssoms@ab-inbev.com                                  E-mail: henry.rudd@ab-inbev.com

      Aimee Baxter                                                           Mariusz Jamka
      Tel: +1-718-650-4003                                                   Tel: +32-16-27-68-88
      E-mail: aimee.baxter@ab-inbev.com                                      E-mail: mariusz.jamka@ab-inbev.com

      Peter Dercon                                                           Lauren Abbott
      Tel: +32-16-27-68-23                                                   Tel: +1-212-573-9287
      E-mail: peter.dercon@ab-inbev.com                                      E-mail: lauren.abbott@ab-inbev.com

      About Anheuser-Busch InBev
      Anheuser-Busch InBev is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico
      (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock
      Exchange (NYSE: BUD). Our Dream is to bring people together for a better world. Beer, the original social network, has been bringing
      people together for thousands of years. We are committed to building great brands that stand the test of time and to brewing the best
      beers using the finest natural ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®,
      Corona® and Stella Artois®; multi-country brands Beck’s®, Castle®, Castle Lite®, Hoegaarden® and Leffe®; and local champions
      such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Chernigivske®, Cristal®, Harbin®, Jupiler®, Klinskoye®, Michelob
      Ultra®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, Sibirskaya Korona® and Skol®. Our brewing heritage dates back more
      than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To
      the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the
      Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed
      and developing markets, we leverage the collective strengths of approximately 200 000 employees based in more than 50 countries
      worldwide. For 2016, AB InBev’s reported revenue was 45.5 billion USD (excluding JVs and associates).


      26 October 2017
      JSE Sponsor: Deutsche Securities (SA) Proprietary Limited




ab-inbev.com                                                                                                                           15
      Annex 1
      AB InBev Worldwide                                      3Q16    Scope       Currency     Organic       3Q17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                          162 944      100               -     -2 000    161 045     -1.2%
                       of which AB InBev own beer           134 913    - 200               -     -1 987    132 725     -1.5%
      Revenue                                                14 210    - 121            151         500     14 740      3.6%
      Cost of sales                                          -5 698        98           - 50        105     -5 546      1.9%
      Gross profit                                            8 511       -22           100         604      9 194      7.1%
      SG&A                                                   -4 716      - 35           - 63        162     -4 652      3.4%
      Other operating income/(expenses)                         200         7              3        - 71       139    -34.4%
      Normalized EBIT                                         3 995      - 50             41        695      4 681     17.6%
      Normalized EBITDA                                       5 039      - 49             52        691      5 733     13.8%
      Normalized EBITDA margin                               35.5%                                          38.9%    353 bps

      North America                                           3Q16    Scope       Currency     Organic       3Q17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                           31 912     137               -      -1 939     30 109     -6.1%
      Revenue                                                 4 287       43             16       - 226      4 120      -5.3%
      Cost of sales                                          -1 579     - 26             -5         110     -1 500       7.0%
      Gross profit                                            2 709       16             11       - 116      2 621      -4.3%
      SG&A                                                   -1 183     - 15             -6           90    -1 115       7.6%
      Other operating income/(expenses)                          10        -              -           -7         3    -72.4%
      Normalized EBIT                                         1 536        1              5         - 34     1 508     -2.2%
      Normalized EBITDA                                       1 741        3              6         - 25     1 724      -1.4%
      Normalized EBITDA margin                               40.6%                                          41.8%    164 bps

      Latin America West                                      3Q16    Scope       Currency     Organic       3Q17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                           27 152     - 21               -       881      28 012      3.2%
      Revenue                                                 2 161        -              47       193       2 400      8.9%
      Cost of sales                                           - 642        -             -14          4      - 652      0.6%
      Gross profit                                            1 518        1              33       196       1 748     12.9%
      SG&A                                                    - 705     - 11             -17       - 30      - 764     -4.2%
      Other operating income/(expenses)                          22        6               1       - 33         -3         -
      Normalized EBIT                                           835       -5              17       133         981     16.1%
      Normalized EBITDA                                         991       -4              21       129       1 137     13.1%
      Normalized EBITDA margin                               45.9%                                          47.4%    173 bps

      Latin America North                                     3Q16    Scope       Currency     Organic       3Q17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                           28 947        6               -     -1 010     27 943     -3.5%
      Revenue                                                 2 081       -1              29        167      2 276      8.0%
      Cost of sales                                           - 881        -              -9        - 25     - 916     -2.8%
      Gross profit                                            1 198        -              20        142      1 360     11.8%
      SG&A                                                    - 715     - 14            - 11           4     - 736      0.5%
      Other operating income/(expenses)                          95       -1              -1        - 20        74    -20.8%
      Normalized EBIT                                           579     - 14               8        126        698     22.2%
      Normalized EBITDA                                         782     - 14              10        128        906     16.7%
      Normalized EBITDA margin                               37.6%                                          39.8%    298 bps




ab-inbev.com                                                                                                             16
      Annex 1
      Latin America South                                     3Q16    Scope       Currency      Organic      3Q17     Organic
                                                    Reference Base              translation      growth                growth
      Total volumes (thousand hls)                            7 478       -                -        333      7 811        4.5%
      Revenue                                                   677       -             - 62        150        764       22.1%
      Cost of sales                                           - 225      -1               22        - 83     - 287      -36.9%
      Gross profit                                              451       -             - 40          67       478       14.8%
      SG&A                                                    - 173       -               15        - 17     - 175      -10.1%
      Other operating income/(expenses)                           7       -                -          -4         2      -64.4%
      Normalized EBIT                                           287      -2             - 25          45       305       15.8%
      Normalized EBITDA                                         332      -1             - 30          57       359       17.3%
      Normalized EBITDA margin                               49.1%                                          46.9%     -193 bps

      EMEA                                                    3Q16    Scope       Currency      Organic      3Q17     Organic
                                                    Reference Base              translation      growth                growth
      Total volumes (thousand hls)                           35 898     240                -       - 310    35 828      -0.9%
                       of which AB InBev own beer            22 545     244                -       - 114    22 675      -0.5%
      Revenue                                                 2 648       -5            114          119     2 876       4.5%
      Cost of sales                                          -1 213     - 10            - 43           16   -1 250       1.3%
      Gross profit                                            1 435     - 14              70         135     1 626       9.5%
      SG&A                                                    - 857        5            - 39         - 14    - 905      -1.7%
      Other operating income/(expenses)                           8        -                -          25       33           -
      Normalized EBIT                                           586       -9              32         146       755      25.4%
      Normalized EBITDA                                         778       -8              38         160       969      20.8%
      Normalized EBITDA margin                               29.4%                                          33.7%     454 bps

      Asia Pacific                                            3Q16    Scope       Currency      Organic      3Q17     Organic
                                                    Reference Base              translation      growth                growth
      Total volumes (thousand hls)                           31 103     - 91              -           24    31 037       0.1%
      Revenue                                                 2 107       11              7           97     2 221       4.6%
      Cost of sales                                           - 911     - 10             -2           53     - 870       5.8%
      Gross profit                                            1 196        1              4         150      1 351      12.5%
      SG&A                                                    - 747     - 15              1            2     - 759       0.3%
      Other operating income/(expenses)                          41        -              1         - 22        20     -52.3%
      Normalized EBIT                                           490     - 14              6         130        612      27.3%
      Normalized EBITDA                                         668     - 15              8           95       755      14.4%
      Normalized EBITDA margin                               31.7%                                          34.0%     293 bps

      Global Export and Holding                               3Q16    Scope       Currency      Organic      3Q17     Organic
      Companies                                     Reference Base              translation      growth                growth
      Total volumes (thousand hls)                              455    - 172              -           21       304       7.4%
      Revenue                                                   249    - 169              -            1         81      0.9%
      Cost of sales                                           - 246      144              2           30       - 70     29.7%
      Gross profit                                                2      - 24             2           31         10         -
      SG&A                                                    - 338        17            -6         129      - 198      41.8%
      Other operating income/(expenses)                          18         -             2         - 11         10    -59.1%
      Normalized EBIT                                         - 317        -8            -2         149      - 178      47.8%
      Normalized EBITDA                                       - 256        -8             -         147      - 117      58.7%




ab-inbev.com                                                                                                              17
      Annex 2
      AB InBev Worldwide                                      9M16    Scope       Currency     Organic       9M17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                          456 441   11 339              -      -1 185    466 595     -0.3%
                       of which AB InBev own beer           381 022    - 527              -         442    380 938      0.1%
      Revenue                                                39 736        88           429       1 590     41 844      4.1%
      Cost of sales                                         -15 764        24         - 175       - 304    -16 220     -2.0%
      Gross profit                                           23 973      111            254       1 286     25 624      5.4%
      SG&A                                                  -13 291    - 252          - 156         268    -13 431      2.0%
      Other operating income/(expenses)                         692      - 61            19       - 102        547    -16.2%
      Normalized EBIT                                        11 374    - 203            117       1 452     12 741     13.0%
      Normalized EBITDA                                      14 385    - 151            148       1 513     15 895     10.7%
      Normalized EBITDA margin                               36.2%                                          38.0%    230 bps

      North America                                           9M16    Scope       Currency     Organic       9M17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                           90 351      348              -      -3 433     87 265     -3.8%
      Revenue                                                12 082      119              3       - 298     11 906      -2.5%
      Cost of sales                                          -4 481      - 77            -1         172     -4 387      3.8%
      Gross profit                                            7 601        42             2       - 126      7 520      -1.7%
      SG&A                                                   -3 383      - 46            -1         141     -3 289      4.2%
      Other operating income/(expenses)                          41         -             -         - 19        22    -46.4%
      Normalized EBIT                                         4 259        -3             1           -4     4 253     -0.1%
      Normalized EBITDA                                       4 857         1             1           13     4 873      0.3%
      Normalized EBITDA margin                               40.2%                                          40.9%    113 bps

      Latin America West                                      9M16    Scope       Currency     Organic       9M17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                           79 686      - 71              -      1 585     81 200      2.0%
      Revenue                                                 6 284        -1           - 58        435      6 660      6.9%
      Cost of sales                                          -1 841        -1             23        - 59    -1 878     -3.2%
      Gross profit                                            4 443        -1           - 35        376      4 782      8.5%
      SG&A                                                   -2 119      - 36             24          -6    -2 136     -0.3%
      Other operating income/(expenses)                         100      - 60             -1          -9        31    -21.5%
      Normalized EBIT                                         2 424      - 97           - 12        362      2 677     15.5%
      Normalized EBITDA                                       2 894      - 95           - 17        353      3 135     12.6%
      Normalized EBITDA margin                               46.1%                                          47.1%    238 bps

      Latin America North                                     9M16    Scope       Currency     Organic       9M17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                           85 869         1             -      -1 377     84 493      -1.6%
      Revenue                                                 5 901         -           570         171      6 641        2.9%
      Cost of sales                                          -2 267         -         - 235       - 235     -2 736     -10.4%
      Gross profit                                            3 634         -           335         - 65     3 905       -1.8%
      SG&A                                                   -1 938      - 32         - 192           16    -2 146        0.8%
      Other operating income/(expenses)                         286        -1            23         - 76       232     -26.7%
      Normalized EBIT                                         1 983      - 34           166       - 125      1 990      -6.4%
      Normalized EBITDA                                       2 543      - 34           220       - 124      2 605       -4.9%
      Normalized EBITDA margin                               43.1%                                          39.2%    -323 bps




ab-inbev.com                                                                                                              18
      Annex 2
      Latin America South                                     9M16    Scope       Currency     Organic      9M17    Organic
                                                    Reference Base              translation     growth               growth
      Total volumes (thousand hls)                           22 297       -                -      1 333    23 630       6.0%
      Revenue                                                 1 908       -           - 148         527     2 287      27.6%
      Cost of sales                                           - 639       -               48      - 262     - 853     -41.0%
      Gross profit                                            1 268       1           - 100         265     1 434      20.9%
      SG&A                                                    - 495      -3               39      - 109     - 569     -22.0%
      Other operating income/(expenses)                          10      -1                -         -4         5     -47.5%
      Normalized EBIT                                           784      -4             - 62        151       870      19.4%
      Normalized EBITDA                                         917      -4             - 72        183     1 025      20.1%
      Normalized EBITDA margin                               48.1%                                         44.8%    -284 bps

      EMEA                                                    9M16    Scope       Currency     Organic      9M17    Organic
                                                    Reference Base              translation     growth               growth
      Total volumes (thousand hls)                           93 617   11 681               -       156    105 454      0.2%
                       of which AB InBev own beer            63 621      708               -       947     65 277      1.5%
      Revenue                                                 6 789      657            137        438      8 022      6.5%
      Cost of sales                                          -3 061    - 473            - 52       - 70    -3 656     -2.3%
      Gross profit                                            3 729      183              85       369      4 366     10.0%
      SG&A                                                   -2 283    - 178            - 57       - 87    -2 605     -3.8%
      Other operating income/(expenses)                          14        1               3         57        75         -
      Normalized EBIT                                         1 460        6              31       339      1 836     23.6%
      Normalized EBITDA                                       1 987       62              36       373      2 458     19.0%
      Normalized EBITDA margin                               29.3%                                         30.6%    340 bps

      Asia Pacific                                            9M16    Scope       Currency     Organic      9M17    Organic
                                                    Reference Base              translation     growth               growth
      Total volumes (thousand hls)                           83 265    - 111               -       450     83 605      0.5%
      Revenue                                                 5 765        39           - 74       348      6 077      6.0%
      Cost of sales                                          -2 597      - 33             42         88    -2 500      3.4%
      Gross profit                                            3 168         5           - 32       436      3 577     13.8%
      SG&A                                                   -2 029      - 33             31         23    -2 008      1.1%
      Other operating income/(expenses)                         167         -             -3       - 63       102    -37.4%
      Normalized EBIT                                         1 306      - 27             -4       397      1 671     31.0%
      Normalized EBITDA                                       1 849      - 35           - 17       370      2 167     20.2%
      Normalized EBITDA margin                               32.1%                                         35.7%    425 bps

      Global Export and Holding                               9M16    Scope       Currency     Organic      9M17    Organic
      Companies                                     Reference Base              translation     growth               growth
      Total volumes (thousand hls)                            1 357    - 509              -        101        948      11.9%
      Revenue                                                 1 006    - 724              -        - 30       251     -10.8%
      Cost of sales                                           - 877      606              -          60     - 210      22.3%
      Gross profit                                              129    - 118              -          30        41          -
      SG&A                                                   -1 043        75             -        290      - 678      30.6%
      Other operating income/(expenses)                          73        -1            -3          12        81      16.8%
      Normalized EBIT                                         - 841      - 44            -3        332      - 555      38.4%
      Normalized EBITDA                                       - 663      - 45            -3        344      - 367      50.0%




ab-inbev.com                                                                                                            19

Date: 26/10/2017 07:06:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story